Loading...
Loading...
Analysts at Piper Jaffray initiated coverage on shares of CareDx
CDNA with a Overweight rating.
The target price for CareDx is set to $13.
CareDx's shares gained 4.29% to $10.45 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in